Accreditation Statement and Credit Designation  

European Accreditation Council for Continuing Medical Education (UEMS/EACCME) 

An application has been made to the UEMS-EACCME® for CME accreditation for this event.    

American Medical Association (AMA) 

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications  

Royal College of Physicians and Surgeons of Canada  

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada. For more information, visit: https://www.royalcollege.ca/en/standards-and-accreditation/cpd-accreditation/international-agreements-physicians-outside-canada.html  

Educational Objectives  

After participating in this educational event, learners should be able to:

  • Address individual needs in compliance with their Continuous Professional Development (CPD) plan
  • Describe the latest scientific advances in FLASH radiotherapy, particle therapy, and spatially fractionated radiotherapy (SFRT), including their potential applications in cancer treatment.
  • Explain the underlying physical, chemical, and biological mechanisms of FLASH and SFRT, including their effects on normal tissues, tumour response, and the tumour microenvironment.
  • Evaluate emerging evidence from preclinical studies and clinical trials, identifying the potential benefits, limitations, and challenges associated with translating innovative radiotherapy approaches into clinical practice.
  • Compare emerging radiotherapy technologies and treatment delivery techniques, including ultra-high dose rate irradiation, proton and ion therapy, minibeam radiotherapy, and advanced dosimetry methods.
  • Identify key considerations for the safe and effective clinical implementation of FLASH and SFRT, including treatment planning, radiation protection, quality assurance, and patient safety.
  • Assess current research gaps and future directions in innovative radiotherapy, recognising opportunities for multidisciplinary collaboration and further clinical investigation.

Target Audience  

The Flash Radiotherapy and Particle Therapy Conference 2026 is the global meeting place for scientists and clinicians in the field of particle radiotherapy. Because of the diverse, clinically focused educational offering, participants are able to tailor the curriculum to meet the needs of international clinicians of all levels of experience.

Disclosure and Resolution of Personal Conflicts of Interest

In accordance with CME/CPD accreditation criteria and standards for commercial support to ensure balance, independence, objectivity, and scientific rigor, those in control of the educational content must disclose potential or actual conflicts of interest. Disclosure information is evaluated and conflicts of interest are resolved. Disclosure is made to participants prior to the activity. Participants will be asked on the evaluation to assess the objectivity and independence of the event.

  • Disclosure information will be available here one week prior to the event.

Industry Support Disclosure

This event is supported, in part, by funding from industry. All support is managed in strict accordance with CME/CPD accreditation criteria and standards for commercial support. Appropriate acknowledgement of all supporting organisations is made in the programme guide, on the event website, and with signage during the event.

  • View a list of all industry supporters here.

Commitment to the Highest Standards in CME/CPD 

Kenes Group is committed to being a valuable and knowledgeable partner in the design and delivery of educationally strong, independent, transparent, and effective CME/CPD programmes. Kenes is a proud member of the Good CME Practice Group (gCMEp), a member organisation contributing to improving health outcomes by: 

Championing best practice in CME/CPD 

Maintaining and improving standards  

Mentoring and educating  

Working in collaboration with critical stakeholders   

Membership in the Good CME Practice Group illustrates Kenes commitment to high standards and knowledgeable partnership with its clients in the design and delivery of medical events. 

 

EthicalMedTech CVS

EthicalMedTech is a unique platform supported by MedTech Europe and dedicated to ethics and compliance projects in the healthcare sector. It is hosting major industry compliance initiatives – including EFPIA’s evaluation platform for European medical conferences since January 2021.

To view the assessment status of FRPT 2027, please click here.